Cure My Disease

Don't miss your cure!

 Log in / Sign up

Blood loss breakthrough? study tests TXA in fracture patients on anticoagulants

NCT ID NCT07116395

Not yet recruiting Knowledge-focused Sponsor: Arbi Nazarian, MD Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 03, 2026 · Updated 24 times

Summary

This study tests whether tranexamic acid (TXA), a drug that reduces bleeding, can safely lower blood loss in 200 adults with broken leg bones who are also taking blood thinners. Researchers will compare blood loss and hospital stay length between those who get TXA and those who don't. The goal is to see if this common joint-surgery drug can help a wider group of trauma patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PATIENTS UNDERGOING OPERATIVE FIXATION OF LONG BONE FRACTURES WITHIN THE COMMUNITY MEDICAL CENTERS SYSTEM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Community Regional Medical Center

    Fresno, California, 93701, United States

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

PATIENTS UNDERGOING OPERATIVE FIXATION OF LONG BONE FRACTURES WITHIN THE COMMUNITY MEDICAL CENTERS SYSTEM